International biotechnology companies are threatening to move their operations overseas. The threat follows the government’s decision last week to ban clinical trials of animal tissue transplantation into humans.
Cambridge-based Immutran is thought to be leading the possible exodus.
- Sunday Business 19/01/97 page 2
